Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China.
Saved in:
| Title: | Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China. |
|---|---|
| Authors: | Wang W; Department of Hematology, Peking Union Medical College Hospital, 1, Shuaifuyuan Wangfujing, Dongcheng District, Beijing, 100730, China., Zhang W; Department of Hematology, Peking Union Medical College Hospital, 1, Shuaifuyuan Wangfujing, Dongcheng District, Beijing, 100730, China. vv1223@vip.sina.com., Su LP; Department of Hematology, Shanxi Provincial Cancer Hospital, 3 Worker's New Village, Xinghualing District, Taiyuan, Shanxi, China. Sulp2005@sohu.com., Liu LH; Department of Hematology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Gao YH; Department of Hematology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Wang QS; Department of Hematology, Chinese PLA General Hospital, Beijing, China., Su H; Department of Lymphoma, The 307 Hospital of PLA, Beijing, China., Song YQ; Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China., Zhang HL; Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China., Shen J; Department of Hematology, Beijing Friendship Hospital, Beijing, China., Jing HM; Department of Hematology, Peking University Third Hospital, Beijing, China., Wang SY; Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin, China., Cen XN; Department of Hematology, Peking University First Hospital, Beijing, China., Liu H; Department of Hematology, Beijing Hospital, Beijing, China., Liu AC; Department of Lymphoma, Harbin Medical University Cancer Hospital, Harbin, China., Li ZJ; Lymphoma Diagnosis and Treatment Center, Institute of Hematology and Blood Diseases Hospital, Tianjin, China., Luo JM; Department of Hematology, Second Hospital of Hebei Medical University, Shijiazhuang, China., He JX; Department of Hematology, Shanxi Provincial People's Hospital, Taiyuan, China., Wang JW; Department of Hematology, Beijing Tongren Hospital, Beijing, China., O'Connor OA; Columbia University Medical Center, New York, NY, USA., Zhou DB; Department of Hematology, Peking Union Medical College Hospital, 1, Shuaifuyuan Wangfujing, Dongcheng District, Beijing, 100730, China. |
| Source: | Annals of hematology [Ann Hematol] 2024 Aug; Vol. 103 (8), pp. 3061-3069. Date of Electronic Publication: 2024 May 28. |
| Publication Type: | Journal Article; Multicenter Study; Clinical Trial, Phase II; Comparative Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0584 |
|---|---|
| DOI: | 10.1007/s00277-024-05708-w |
